Why do we sleep?
In a study of a small region of the thalamus, MIT neuroscientists have now identified three distinct circuits that influence the development of both motor and nonmotor symptoms of Parkinson’s.
APL researchers are standardizing an amazing collection of high-resolution brain mapping data, an effort that would enable unprecedented analysis and make the Laboratory a focal point for neuroscience research.
Parkinson's disease is marked by the death of dopamine-producing neurons in the brain — specifically in the substantia nigra, a structure deep within a region of the brain called the midbrain.
3 new projects launch on the Allen Institute's OpenScope, a shared neuroscience observatory, supported by the NIH BRAIN Initiative
Researchers have uncovered how signals from a group of neurons in the brain's frontal lobe simultaneously give humans the flexibility to learn new tasks -- and the focus to develop highly specific skills.
UNC School of Medicine researchers led by Ian Shih, Ph.D., used fMRI and a genetic mouse model to study the effects of a neurotransmitter on brain network functional connectivity, a dynamic process crucial for human health and behavior
Implants are becoming more sophisticated — and are attracting commercial interest.
In the diagnosis of disease, doctors often need to take tissue samples and process them for examination under a microscope. Millions of such biopsies are performed in the U.S. every year. But these pose many challenges. Biopsies may damage healthy tissue.
Addgene, the nonprofit biorepository, now produces and distributes ready-to-use recombinant antibodies.
The flexible backing allows arrays of micro-scale needles to conform to the contours of the brain, which improves high-resolution brain recording
Over three years, the work — a collaboration between researchers at Cedars-Sinai in L.A., Boston Children’s, and the University of Toronto — led to the discovery of two new groups of brain cells: boundary and event cells.
Treatment-resistant depression (TRD) is diagnosed after an individual has tried several types of treatment for depression and their symptoms haven’t improved.
While there is currently no cure for blindness, a first-of-its-kind artificial vision system has undergone its first successful implantation, bringing with it the potential to restore partial vision to people who have lost their sight.
Seven Caltech researchers are principal investigators on eight new neuroscience grants from the National Institutes of Health's BRAIN Initiative.
The 2021 cohort of Howard Hughes Medical Institute (HHMI) Investigators includes six BRAIN-funded scientists.
The NIH-led Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative continues to teach us about the world’s most sophisticated computer: the human brain.